Clinical Commissioning Urgent Policy Statement: Subcutaneous copper histidinate injections for presymptomatic neonates with classical Menkes disease

Document first published:
Page updated:
Topic:
,
Publication type:

Subcutaneous copper histidinate injections are recommended to be available through routine commissioning as a treatment option for presymptomatic neonates with classical Menkes disease within the criteria set out in this document.

 

Document

Clinical Commissioning Urgent Policy Statement: Subcutaneous copper histidinate injections for presymptomatic neonates with classical Menkes disease

Clinical Commissioning Urgent Policy Statement: Subcutaneous copper histidinate injections for presymptomatic neonates with classical Menkes disease

  • PDF
  • 319 KB
  • 12 pages